Piu Medical SpAMIL:PMED 13 EBIT per Share is € as of Jun. 2025. GuruFocus rates MIL:PMED with a GF Score™ of 13/100. The stock has 4 warning signs investors should review. Among 530 Healthcare Providers & Services companies, Piu Medical SpA ranks worse than 188679.06% on this metric.
Piu Medical SpA's EBIT per Share for the
six
months ended in Jun. 2025 was €0.10.
Piu Medical SpA does not have enough years/quarters to calculate its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2025.
During the past 12 months, the average EBIT per Share Growth Rate of Piu Medical SpA was -94.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Piu Medical SpA's EBIT per Share or its related term are showing as below:
MIL:PMED's 3-Year EBIT Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 11.85 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Piu Medical SpA (MIL:PMED) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Piu Medical SpA EBIT per Share Related Terms
Piu Medical SpA EBIT per Share Historical Data
* Premium members only.
The historical data trend for Piu Medical SpA's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Piu Medical SpA (MIL:PMED) has a EBIT per Share of € as of Jun. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Piu Medical SpA and its competitors. According to the industry distribution chart, Piu Medical SpA ranks #999999 out of 530 companies in the Healthcare Providers & Services industry.
Is Piu Medical SpA's EBIT per Share too high?
Piu Medical SpA's current EBIT per Share is €. Based on the distribution chart, Piu Medical SpA ranks #999999 out of 530 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Piu Medical SpA has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Piu Medical SpA's EBIT per Share compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Piu Medical SpA ranks #999999 out of 530 companies for EBIT per Share. This places Piu Medical SpA in the lower half of its industry. The industry median EBIT per Share is 11.85. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.85, based on 530 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Piu Medical SpA and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Piu Medical SpA's current EBIT per Share is €. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Piu Medical SpA stock overvalued right now?
Piu Medical SpA (MIL:PMED) has a current EBIT per Share of €. The current EBIT per Share is €. Piu Medical SpA's overall GF Score™ is 13/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Piu Medical SpA (MIL:PMED), the current EBIT per Share is € as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Piu Medical SpA specializes in the retail distribution of pharmaceutical and parapharmaceutical products. Its activity includes: sale of prescription drugs; sale of OTC and parapharmaceutical products: OTC medicines, dietary supplements, medical devices, paramedical products, personal care and wellness products, homeopathic medicines, cosmetics, etc.; services: diagnostic testing services, blood parameter analysis and control (glycemia, cholesterol, triglycerides, etc.), rapid testing and screening, nutritional consultation, remote medical assistance and monitoring, telemedicine, etc.
13GF Score
Get the complete analysis for MIL:PMED
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:PMED has been successfully added to your 